Zhou Shaoman, Breitenbach Julie M, Borysko Katherine Z, Drach John C, Kern Earl R, Gullen Elizabeth, Cheng Yung-Chi, Zemlicka Jiri
Department of Chemistry, Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201-1379, USA.
J Med Chem. 2004 Jan 29;47(3):566-75. doi: 10.1021/jm030316s.
The second generation of methylenecyclopropane analogues of nucleosides 5a-5i and 6a-6i was synthesized and evaluated for antiviral activity. The 2,2-bis(hydroxymethyl)methylenecyclopropane (11) was converted to dibromo derivative 7 via acetate 12. Alkylation-elimination of adenine (16) with 7 afforded the Z/E mixture of acetates 17 + 18, which was deacetylated to give analogues 5a and 6a separated by chromatography. A similar reaction with 2-amino-6-chloropurine (19) afforded acetates 20 + 21 and, after deprotection and separation, isomers 5f and 6f. The latter served as starting materials for synthesis of analogues 5b, 5e, 5g-5i and 6b, 6e, 6g-6i. Alkylation-elimination of N(4)-acetylcytosine (22) with 7 afforded a mixture of isomers 5c + 6c which were separated via N(4)-benzoyl derivatives 23 and 24. Deprotection furnished analogues 5c and 6c. Alkylation of 2,4-bis(trimethylsilyloxy)-5-methylpyrimidine (25) with 7 led to bromo derivative 26. Elimination of HBr followed by deacetylation and separation gave thymine analogues 5d and 6d. The guanine Z-isomer 5b was the most effective against human and murine cytomegalovirus (HCMV and MCMV) with EC(50) = 0.27-0.49 microM and no cytotoxicity. The 6-methoxy analogue 5g was also active (EC(50) = 2.0-3.5 microM) whereas adenine Z-isomer 5a was less potent (EC(50) = 3.6-11.7 microM). Cytosine analogue 5c was moderately effective, but 2-amino-6-cyclopropylamino derivative 5e was inactive. All E-isomers were devoid of anti-CMV activity, and none of the analogues was significantly active against herpes simplex viruses (HSV-1 or HSV-2). The potency against Epstein-Barr virus (EBV) was assay-dependent. In Daudi cells, the E-isomers of 2-amino-6-cyclopropylamino- and 2,6-diaminopurine derivatives 6e and 6h were the most potent (EC(50) approximately 0.3 microM), whereas only the thymine Z-isomer 5d was active (EC(50) = 4.6 microM). Guanine Z-derivative 5b was the most effective compound in H-1 cells (EC(50) = 7 microM). In the Z-series, the 2-amino-6-methoxypurine analogue 5g was the most effective against varicella zoster virus (VZV, EC(50) = 3.3 microM) and 2,6-diaminopurine 5h against hepatitis B virus (HBV, EC(50) = 4 microM). Adenine analogues 5a and 6a were moderately active as substrates for adenosine deaminase.
合成了第二代核苷5a - 5i和6a - 6i的亚甲基环丙烷类似物,并对其抗病毒活性进行了评估。2,2 - 双(羟甲基)亚甲基环丙烷(11)通过乙酸酯12转化为二溴衍生物7。7与腺嘌呤(16)进行烷基化 - 消除反应得到乙酸酯17 + 18的Z/E混合物,将其脱乙酰化后通过色谱法分离得到类似物5a和6a。与2 - 氨基 - 6 - 氯嘌呤(19)进行类似反应得到乙酸酯20 + 21,经过脱保护和分离后得到异构体5f和6f。后者用作合成类似物5b、5e、5g - 5i和6b、6e、6g - 6i的起始原料。7与N(4) - 乙酰胞嘧啶(22)进行烷基化 - 消除反应得到异构体5c + 6c的混合物,通过N(4) - 苯甲酰基衍生物23和24将其分离。脱保护得到类似物5c和6c。7与2,4 - 双(三甲基硅氧基)- 5 - 甲基嘧啶(25)进行烷基化反应得到溴衍生物26。消除HBr后进行脱乙酰化和分离得到胸腺嘧啶类似物5d和6d。鸟嘌呤Z - 异构体5b对人巨细胞病毒和鼠巨细胞病毒(HCMV和MCMV)最有效,EC(50) = 0.27 - 0.49 μM且无细胞毒性。6 - 甲氧基类似物5g也有活性(EC(50) = 2.0 - 3.5 μM),而腺嘌呤Z - 异构体5a效力较低(EC(50) = 3.6 - 11.7 μM)。胞嘧啶类似物5c有中等效果,但2 - 氨基 - 6 - 环丙基氨基衍生物5e无活性。所有E - 异构体均无抗CMV活性,且没有一种类似物对单纯疱疹病毒(HSV - 1或HSV - 2)有显著活性。对爱泼斯坦 - 巴尔病毒(EBV)的效力取决于测定方法。在Daudi细胞中,2 - 氨基 - 6 - 环丙基氨基和2,6 - 二氨基嘌呤衍生物6e和6h的E - 异构体最有效(EC(50)约为0.3 μM),而只有胸腺嘧啶Z - 异构体5d有活性(EC(50) = 4.6 μM)。鸟嘌呤Z - 衍生物5b在H - 1细胞中是最有效的化合物(EC(50) = 7 μM)。在Z系列中,2 - 氨基 - 6 - 甲氧基嘌呤类似物5g对水痘带状疱疹病毒最有效(VZV,EC(50) = 3.3 μM),2,6 - 二氨基嘌呤5h对乙型肝炎病毒(HBV,EC(50) = 4 μM)最有效。腺嘌呤类似物5a和6a作为腺苷脱氨酶的底物有中等活性。